These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The relationship between osteoporosis and periodontitis in women aged 45-70 years. Pepelassi E, Nicopoulou-Karayianni K, Archontopoulou AD, Mitsea A, Kavadella A, Tsiklakis K, Vrotsos I, Devlin H, Horner K. Oral Dis; 2012 May; 18(4):353-9. PubMed ID: 22151499 [Abstract] [Full Text] [Related]
29. [Relationship between periodontitis and osteoporosis in postmenopausal women]. Zhu J, Li JH, Yuan TT, He L, Liang YH. Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec 18; 51(6):1115-1118. PubMed ID: 31848514 [Abstract] [Full Text] [Related]
30. Association of bone mineral density with periodontal status in postmenopausal women. Singh A, Sharma RK, Siwach RC, Tewari S, Narula SC. J Investig Clin Dent; 2014 Nov 18; 5(4):275-82. PubMed ID: 23766246 [Abstract] [Full Text] [Related]
32. Clinical results of alendronate monotherapy and combined therapy with menatetrenone (VitK₂) in postmenopausal RA patients. Suzuki K, Tsuji S, Fukushima Y, Nakase T, Hamada M, Tomita T, Yoshikawa H. Mod Rheumatol; 2013 May 18; 23(3):450-5. PubMed ID: 22692649 [Abstract] [Full Text] [Related]
33. Once-weekly alendronate 70 mg and raloxifene 60 mg daily in the treatment of postmenopausal osteoporosis. Luckey M, Kagan R, Greenspan S, Bone H, Kiel RD, Simon J, Sackarowitz J, Palmisano J, Chen E, Petruschke RA, de Papp AE. Menopause; 2004 May 18; 11(4):405-15. PubMed ID: 15243278 [Abstract] [Full Text] [Related]
34. Effectiveness of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid laminin-5 gamma2 chain levels in chronic periodontitis. Emingil G, Atilla G, Sorsa T, Savolainen P, Baylas H. J Periodontol; 2004 Oct 18; 75(10):1387-96. PubMed ID: 15562917 [Abstract] [Full Text] [Related]
35. Treatment of intrabony defects using guided tissue regeneration or enamel matrix derivative: a 3-year prospective randomized clinical study. Crea A, Dassatti L, Hoffmann O, Zafiropoulos GG, Deli G. J Periodontol; 2008 Dec 18; 79(12):2281-9. PubMed ID: 19053918 [Abstract] [Full Text] [Related]
36. A novel effervescent formulation of oral weekly alendronate (70 mg) improves persistence compared to alendronate tablets in post-menopausal women with osteoporosis. Giusti A, Bianchi G, Barone A, Black DM. Aging Clin Exp Res; 2021 Sep 18; 33(9):2529-2537. PubMed ID: 33449337 [Abstract] [Full Text] [Related]
37. Effect of 1% sodium alendronate in the non-surgical treatment of periodontal intraosseous defects: a 6-month clinical trial. Dutra BC, Oliveira AMSD, Oliveira PAD, Manzi FR, Cortelli SC, Cota LOM, Costa FO. J Appl Oral Sci; 2017 Sep 18; 25(3):310-317. PubMed ID: 28678950 [Abstract] [Full Text] [Related]
39. Clinical and microbiological effects of initial periodontal therapy in conjunction with amoxicillin and clavulanic acid in patients with adult periodontitis. A randomised double-blind, placebo-controlled study. Winkel EG, van Winkelhoff AJ, Barendregt DS, van der Weijden GA, Timmerman MF, van der Velden U. J Clin Periodontol; 1999 Jul 18; 26(7):461-8. PubMed ID: 10412851 [Abstract] [Full Text] [Related]
40. The effect of alendronate sodium on alveolar bone loss in periodontitis (clinical trial). El-Shinnawi UM, El-Tantawy SI. J Int Acad Periodontol; 2003 Jan 18; 5(1):5-10. PubMed ID: 12666950 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]